205 related articles for article (PubMed ID: 29681617)
21. Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
He Y; Liu J; Zhao Z; Zhao H
Dis Esophagus; 2017 May; 30(5):1-8. PubMed ID: 28375447
[TBL] [Abstract][Full Text] [Related]
22. Construction of a 5-feature gene model by support vector machine for classifying osteoporosis samples.
Hu M; Zou L; Lu J; Yang Z; Chen Y; Xu Y; Sun C
Bioengineered; 2021 Dec; 12(1):6821-6830. PubMed ID: 34622712
[TBL] [Abstract][Full Text] [Related]
23. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
Tuo Y; An N; Zhang M
Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
[TBL] [Abstract][Full Text] [Related]
24. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.
Martinez-Barbera JP
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):721-32. PubMed ID: 25611703
[TBL] [Abstract][Full Text] [Related]
25. A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma.
Wang R; Cai Y; Zhang B; Wu Z
Int J Mol Med; 2018 Mar; 41(3):1377-1384. PubMed ID: 29286069
[TBL] [Abstract][Full Text] [Related]
26. High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children.
Gong J; Zhang H; Xing S; Li C; Ma Z; Jia G; Hu W
Cancer Biomark; 2014; 14(4):241-51. PubMed ID: 24934367
[TBL] [Abstract][Full Text] [Related]
27. A 80-gene set potentially predicts the relapse in laryngeal carcinoma optimized by support vector machine.
Yang B; Guo Q; Wang F; Cai K; Bao X; Chu J
Cancer Biomark; 2017; 19(1):65-73. PubMed ID: 28269752
[TBL] [Abstract][Full Text] [Related]
28. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
29. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
[TBL] [Abstract][Full Text] [Related]
30. Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics.
Robinson LC; Santagata S; Hankinson TC
Neurosurg Focus; 2016 Dec; 41(6):E3. PubMed ID: 27903126
[TBL] [Abstract][Full Text] [Related]
31. Support vector machine classifier for prediction of the metastasis of colorectal cancer.
Zhi J; Sun J; Wang Z; Ding W
Int J Mol Med; 2018 Mar; 41(3):1419-1426. PubMed ID: 29328363
[TBL] [Abstract][Full Text] [Related]
32. Differential Expression of Stem Cell Markers in Human Adamantinomatous Craniopharyngioma and Pituitary Adenoma.
Chang CV; Araujo RV; Cirqueira CS; Cani CM; Matushita H; Cescato VA; Fragoso MC; Bronstein MD; Zerbini MC; Mendonca BB; Carvalho LR
Neuroendocrinology; 2017; 104(2):183-193. PubMed ID: 27161333
[TBL] [Abstract][Full Text] [Related]
33. Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
Zhang Y; Fang L; Zang Y; Xu Z
Med Sci Monit; 2018 May; 24():3024-3033. PubMed ID: 29739919
[TBL] [Abstract][Full Text] [Related]
34. Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas.
Gomes DC; Jamra SA; Leal LF; Colli LM; Campanini ML; Oliveira RS; Martinelli CE; Elias PC; Moreira AC; Machado HR; Saggioro F; Neder L; Castro M; Antonini SR
Eur J Endocrinol; 2015 May; 172(5):603-8. PubMed ID: 25693592
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
[TBL] [Abstract][Full Text] [Related]
36. TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.
Liu Y; Wang CH; Li DL; Zhang SC; Peng YP; Peng JX; Song Y; Qi ST; Pan J
Oncotarget; 2016 Aug; 7(31):50564-50574. PubMed ID: 27409178
[TBL] [Abstract][Full Text] [Related]
37. A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma.
Yuan F; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Cong Z; Ma C
Front Neurol; 2021; 12():704130. PubMed ID: 34966342
[TBL] [Abstract][Full Text] [Related]
38. MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and
Li M; Zhou L; Li S; Fang L; Yang L; Wu X; Yang C; Bao Y; Lan S; Tong Z; Zheng S; Tang B; Zeng E; Xie S; Chen C; Hong T
Oncol Lett; 2021 Jul; 22(1):536. PubMed ID: 34084216
[TBL] [Abstract][Full Text] [Related]
39. Transcription Factor GLI1 Induces IL-6-Mediated Inflammatory Response and Facilitates the Progression of Adamantinomatous Craniopharyngioma.
Zhao J; Yang Y; Pan Y; Zhou P; Wang J; Zheng Y; Zhang X; Zhai S; Zhang X; Li L; Yang D
ACS Chem Neurosci; 2023 Sep; 14(18):3347-3356. PubMed ID: 37691264
[TBL] [Abstract][Full Text] [Related]
40. Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing.
He J; Zeng Z; Wang Y; Deng J; Tang X; Liu F; Huang J; Chen H; Liang R; Zan X; Liu Z; Tong A; Guo G; Xu J; Zhu X; Zhou L; Peng Y
Mol Cancer; 2021 Dec; 20(1):168. PubMed ID: 34922552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
